Chinese expert consensus on the application of live combined Bifidobacterium, Lactobacillus, and Enterococcus powder/capsule in digestive system diseases (2021)

Author:

Fang Jingyuan1ORCID,Yang Yunsheng2,Xie Weifen3ORCID

Affiliation:

1. Department of Gastroenterology, Renji Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

2. Department of Gastroenterology First Medical Center, Chinese PLA General Hospital Beijing China

3. Department of Gastroenterology Shanghai Changzheng Hospital Shanghai China

Abstract

AbstractBackground and AimDisturbance of gut microbiota is associated with pathological change in multiple diseases. Probiotics can improve symptoms and exert clinical effects via regulation of gastrointestinal microecological environments, and a probiotic product commonly dispensed by Chinese physicians is a combination of live Bifidobacterium, Lactobacillus, and Enterococcus in powder/capsule form. It contains three strains—of Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis—which can act synergistically to balance the microbiome, regulate immunity, and repair the gut barrier. Although this product has been proven safe and effective in clinical practice, uncertainty remains regarding its use to treat digestive system diseases. To date, there have been no reference standards to guide clinical practice and no relevant expert consensus on this product, in China.MethodsFollowing a literature search, evidence was graded and classified according to the grading of recommendations assessment, development, and evaluation (GRADE) system and consensus was secured from a panel of 52 experts.ResultsAn expert consensus has been formed, on the clinical application of live combined Bifidobacterium, Lactobacillus, and Enterococcus in various digestive system diseases, to provide reference for its clinical use.ConclusionsBifidobacterium triple viable powder/capsule may offer benefits, by regulating the balance of intestinal microecology. It can be used for the treatment and prevention of various digestive system diseases with good overall safety; further research is needed to confirm its application in other contexts. The recommendations in this consensus will be confirmed or refined in light of future research and clinical practice.

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Reference61 articles.

1. GRADE guidelines: 3. Rating the quality of evidence

2. A Meta‐analysis of Bifidobacterium viable triple capsule on Helicobacter pylori eradication during clinical therapy;Liu L;J. Pharm. Pract.,2016

3. Clinical observation on bifico combined with triple therapy for eradication of Helicobacter pylori;Peng DZ;Chin. J. Biochem. Drugs.,2014

4. Comparison of the efficacy of standard triple therapy and the addition of probiotics in Helicobacter pylori infection;Zhang LY;Chin. J. Dig.,2013

5. Application of Bifico and bismuth quadruple in elderly peptic ulcer treatment of Helicobacter pylori infection;Wang YM;Chin. J. Nosocomiol.,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3